Li Dan, Peng Cheng, Xie Xiaofang, Mao Yu, Li Min, Cao Zhixing, Fan Danqing
Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China; State Key Laboratory Breeding Base of Systematic Research Development and Utilization of Chinese Medicine Resources Co-Founded by Sichuan Province and MOST, Chengdu 611137, PR China.
Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China; State Key Laboratory Breeding Base of Systematic Research Development and Utilization of Chinese Medicine Resources Co-Founded by Sichuan Province and MOST, Chengdu 611137, PR China.
J Ethnopharmacol. 2014 May 14;153(3):561-7. doi: 10.1016/j.jep.2014.02.026. Epub 2014 Feb 28.
The leaf of Malus toringoides (Rehd.) Hughes is a traditional folk medicine in Tibet, China, which is called "E Se" in Tibetan language. This original plant grows on snow mountains at an attitude of 3000 to 3700 m. It is primarily used to treat hypertension, hyperlipidemia, hyperglycemia, indigestion and other diseases. This study aimed to evaluate the antidiabetic effect of flavonoids extracted from E Se (ESF) and to explore the potential mechanism in streptozotocin (STZ) or alloxan (ALX) induced diabetic mice and STZ-induced diabetic rats.
72 h after the establishment of a diabetic model, STZ or ALX induced diabetic mice and STZ-induced diabetic rats were treated daily with ESF at doses of 45, 90, 180 mg/kg and 37.5, 75, 150 mg/kg, respectively. Both mice and rats were fasted for 5h before administration and the blood glucose (BG) levels were tested 1h after treatment. Body weight was determined every other day. For STZ-induced rats, glycosylated hemoglobin (Hb1Ac), serum insulin and c-peptide, hepatic glycogen, superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels in liver were assessed on the fourth day after BG level detection.
Compared with the model group, the general behavior of mice treated with ESF (90, 180 mg/kg) and rats treated with ESF (75, 150 mg/kg) became better and BG levels were significantly reduced (P<0.05). Significant decrease (P<0.05) in Hb1Ac level was observed in ESF-treated rats compared with diabetic rats. Significant increase (P<0.05 ) in serum insulin and c-peptide were detected in ESF-treated rats. The treatment also significantly (P<0.05) elevated SOD activity and reduced MDA level in the liver of diabetic rats. Besides, ESF 150 mg/kg had a trend of rising hepatic glycogen content of diabetic rats.
The findings of this study suggest that flavonoids from the Malus toringoides (Rehd.) Hughes leaves may possess an antidiabetic activity in animals with established diabetes.
变叶海棠(Rehd.)Hughes的叶子是中国西藏的一种传统民间药物,藏语称为“E Se”。这种原生植物生长在海拔3000至3700米的雪山上。它主要用于治疗高血压、高脂血症、高血糖、消化不良等疾病。本研究旨在评估从E Se中提取的黄酮类化合物(ESF)的抗糖尿病作用,并探讨其在链脲佐菌素(STZ)或四氧嘧啶(ALX)诱导的糖尿病小鼠和STZ诱导的糖尿病大鼠中的潜在机制。
糖尿病模型建立72小时后,STZ或ALX诱导的糖尿病小鼠和STZ诱导的糖尿病大鼠分别每日给予45、90、180mg/kg和37.5、75、150mg/kg剂量的ESF。小鼠和大鼠在给药前禁食5小时,并在治疗后1小时检测血糖(BG)水平。每隔一天测定体重。对于STZ诱导的大鼠,在检测BG水平后的第四天评估糖化血红蛋白(Hb1Ac)、血清胰岛素和C肽、肝糖原、肝脏中超氧化物歧化酶(SOD)活性和丙二醛(MDA)水平。
与模型组相比,ESF(90、180mg/kg)处理的小鼠和ESF(75、150mg/kg)处理的大鼠的一般行为有所改善,BG水平显著降低(P<0.05)。与糖尿病大鼠相比,ESF处理的大鼠Hb1Ac水平显著降低(P<0.05)。ESF处理的大鼠血清胰岛素和C肽显著增加(P<0.05)。该处理还显著(P<0.05)提高了糖尿病大鼠肝脏中的SOD活性并降低了MDA水平。此外,150mg/kg的ESF有使糖尿病大鼠肝糖原含量升高的趋势。
本研究结果表明,变叶海棠(Rehd.)Hughes叶中的黄酮类化合物可能对已患糖尿病的动物具有抗糖尿病活性。